|
16 Sep 2025 |
Dr. Reddy's Labs
|
Consensus Share Price Target
|
1300.80 |
1287.37 |
- |
-1.03 |
hold
|
|
|
|
|
29 Jun 2022
|
Dr. Reddy's Labs
|
Axis Direct
|
1300.80
|
4750.00
|
4364.35
(-70.19%)
|
Target met |
Buy
|
|
|
We recommend a BUY rating on the stock with a TP of Rs 4,750.
|
|
24 Jun 2022
|
Dr. Reddy's Labs
|
ICICI Securities Limited
|
1300.80
|
4925.00
|
4294.90
(-69.71%)
|
Target met |
Buy
|
|
|
DRL has devised a two-pronged strategy to drive long-term growth, classified as Horizon 1 and Horizon 2. Horizon 1 – Growing the core, short-medium term drivers of growth. ? Horizon 2 Building the future, short-long term drivers of growth
|
|
23 Jun 2022
|
Dr. Reddy's Labs
|
Geojit BNP Paribas
|
1300.80
|
5026.00
|
4309.65
(-69.82%)
|
Pre-Bonus/ Split |
Buy
|
|
|
|
|
22 Jun 2022
|
Dr. Reddy's Labs
|
ICICI Direct
|
1300.80
|
4960.00
|
4260.90
(-69.47%)
|
Target met |
Buy
|
|
|
|
|
22 Jun 2022
|
Dr. Reddy's Labs
|
Prabhudas Lilladhar
|
1300.80
|
4900.00
|
4294.90
(-69.71%)
|
Target met |
Buy
|
|
|
|
|
22 Jun 2022
|
Dr. Reddy's Labs
|
BOB Capital Markets Ltd.
|
1300.80
|
4450.00
|
4309.65
(-69.82%)
|
Target met |
Hold
|
|
|
DRRD unveiled a framework to make its business future ready
|
|
21 May 2022
|
Dr. Reddy's Labs
|
Sharekhan
|
1300.80
|
5550.00
|
4390.50
(-70.37%)
|
Pre-Bonus/ Split |
Buy
|
|
|
|
|
20 May 2022
|
Dr. Reddy's Labs
|
ICICI Direct
|
1300.80
|
4800.00
|
4249.10
(-69.39%)
|
Target met |
Buy
|
|
|
|
|
20 May 2022
|
Dr. Reddy's Labs
|
BOB Capital Markets Ltd.
|
1300.80
|
4450.00
|
4249.10
(-69.39%)
|
Target met |
Hold
|
|
|
India, Russia, US and one-off opportunities drove 15% YoY sales growth in Q4; non-core brands divested in Russia and India
|
|
20 May 2022
|
Dr. Reddy's Labs
|
Motilal Oswal
|
1300.80
|
4800.00
|
4249.10
(-69.39%)
|
Target met |
Buy
|
|
|
|